No writing assistance was utilized in the production of this manuscript. Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting ...

Mice with active infections had EcoHIV, the mouse equivalent of human HIV-1. Using CRISPR/Cas9, researchers were able to block replication of the virus and show they could potentially prevent ...

Globally, people get animal protein mostly from chickens, with pigs and cattle in second and third place. A 2023 report ...

Penn has undergone numerous advancements, including the creation of new undergraduate majors, campus development projects, ...

EBT-107 is a CRISPR-based gene therapy that is being developed as a potential cure for chronic hepatitis B. The CRISPR/Cas gene editing system is formulated in lipid nanoparticles (LNPs) and is ...

At the upcoming annual meeting of the American Society of Gene and Cell Therapy, scientists from Huidagene Therapeutics will share an update on the development of their CRISPR-high-fidelity(hf ...

Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline. CRISPR Therapeutics (NasdaqGM:CRSP) recently announced its Q1 2025 earnings, reporting a 71% ...